Hot Line IV: Late-breaking trials on heart failure and acute coronary syndrome EurekAlert (press release) AMSTERDAM, The Netherlands – The blood pressure lowering drug aliskiren did not improve coronary artery disease when given to patients who had prehypertension, results of the Aliskiren Quantitative Atherosclerosis Regression Intravascular Ultrasound ... |
